全文获取类型
收费全文 | 32831篇 |
免费 | 2832篇 |
国内免费 | 1024篇 |
专业分类
耳鼻咽喉 | 308篇 |
儿科学 | 602篇 |
妇产科学 | 527篇 |
基础医学 | 5058篇 |
口腔科学 | 954篇 |
临床医学 | 2951篇 |
内科学 | 6116篇 |
皮肤病学 | 696篇 |
神经病学 | 2809篇 |
特种医学 | 1212篇 |
外国民族医学 | 2篇 |
外科学 | 4337篇 |
综合类 | 2403篇 |
一般理论 | 9篇 |
预防医学 | 1977篇 |
眼科学 | 699篇 |
药学 | 3084篇 |
中国医学 | 400篇 |
肿瘤学 | 2543篇 |
出版年
2023年 | 126篇 |
2022年 | 295篇 |
2021年 | 529篇 |
2020年 | 328篇 |
2019年 | 458篇 |
2018年 | 722篇 |
2017年 | 589篇 |
2016年 | 584篇 |
2015年 | 672篇 |
2014年 | 848篇 |
2013年 | 1089篇 |
2012年 | 1483篇 |
2011年 | 1476篇 |
2010年 | 939篇 |
2009年 | 779篇 |
2008年 | 1308篇 |
2007年 | 1444篇 |
2006年 | 1299篇 |
2005年 | 1085篇 |
2004年 | 975篇 |
2003年 | 896篇 |
2002年 | 754篇 |
2001年 | 2337篇 |
2000年 | 2226篇 |
1999年 | 1846篇 |
1998年 | 686篇 |
1997年 | 455篇 |
1996年 | 320篇 |
1995年 | 285篇 |
1994年 | 249篇 |
1993年 | 229篇 |
1992年 | 1011篇 |
1991年 | 897篇 |
1990年 | 809篇 |
1989年 | 894篇 |
1988年 | 807篇 |
1987年 | 749篇 |
1986年 | 693篇 |
1985年 | 616篇 |
1984年 | 387篇 |
1983年 | 324篇 |
1982年 | 185篇 |
1981年 | 142篇 |
1980年 | 121篇 |
1979年 | 206篇 |
1974年 | 86篇 |
1973年 | 93篇 |
1972年 | 92篇 |
1971年 | 94篇 |
1968年 | 86篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
81.
82.
83.
Genomewide Association Study Identifies Cxcl Family Members as Partial Mediators of LPS‐Induced Periodontitis 下载免费PDF全文
84.
85.
86.
Amy T. Peters Katie L. Burkhouse Autumn Kujawa Kaveh Afshar Kate D. Fitzgerald Christopher S. Monk Greg Hajcak K. Luan Phan 《Developmental psychobiology》2019,61(1):69-80
Anxiety disorders are associated with enhanced error-related negativity (ERN) across development but it remains unclear whether alterations in brain electrophysiology are linked to the timing of puberty. Pubertal timing and alterations of prefrontal and limbic development are implicated in risk for depression, but the interplay of these factors on the ERN–anxiety association has not been assessed. We examined the unique and interactive effects of pubertal timing and depression on the ERN in a sample of youth 10–19 years old with anxiety disorders (n = 30) or no history of psychopathology (n = 30). Earlier pubertal maturation was associated with an enhanced ERN. Among early, but not late maturing youth, higher depressive symptoms were associated with a reduced ERN. The magnitude of neural reactivity to errors is sensitive to anxiety, depression, and development. Early physical maturation and anxiety may heighten neural sensitivity to errors yet predict opposing effects in the context of depression. 相似文献
87.
Noriko Inagaki‐Katashiba Tomoki Ito Muneo Inaba Yoshiko Azuma Akihiro Tanaka Vien Phan Kayoko Kibata Atsushi Satake Shosaku Nomura 《European journal of immunology》2019,49(11):2051-2062
DCs and epithelial cell‐derived thymic stromal lymphopoietin (TSLP) have pivotal roles in allergic inflammation. TSLP stimulates myeloid DCs to express OX40‐ligand (OX40L) and CCL17, which trigger and maintain Th2 cell responses. We have previously shown that statins, which are HMG‐CoA reductase inhibitors, have the ability to suppress type I IFN production by plasmacytoid DCs. Here, we extended our previous work to examine the immunomodulatory effect of statins on allergic responses, particularly the TSLP‐dependent Th2 pathway induced by myeloid DCs. We found that treatment of TSLP‐stimulated DCs with either pitavastatin or simvastatin suppressed both the DC‐mediated inflammatory Th2 cell differentiation and CRTH2+CD4+ memory Th2 cell expansion and also repressed the expressions of OX40L and CCL17 by DCs. These inhibitory effects of statins were mimicked by treatment with either a geranylgeranyl‐transferase inhibitor or Rho‐kinase inhibitor and were counteracted by the addition of mevalonate, suggesting that statins induce geranylgeranylated Rho inactivation through a mevalonate‐dependent pathway. We also found that statins inhibited the expressions of phosphorylated STA6 and NF‐κB‐p50 in TSLP‐stimulated DCs. This study identified a specific ability of statins to control DC‐mediated Th2 responses, suggesting their therapeutic potential for treating allergic diseases. 相似文献
88.
This study intends to report the first emergence of lumpy skin disease (LSD) in Iraq, in addition to describing its related clinical signs. In August 2013, 21 cases of four outbreaks developed clinical signs suggestive of LSD in the Nineveh (Mosul) and Baghdad Governorates, which were considered as the first infected foci of LSD in Iraq. The disease was diagnosed tentatively, on the basis of clinical signs and epidemiological features, and it was confirmed as positive by the polymerase chain reaction and histopathological features. In September 2013, eight new outbreaks of LSD also appeared in Baghdad and Nineveh. In 2014, the disease spread rapidly to the governorates of Kirkuk, Salah Al‐Din, Al‐Anbar, Diyala, Wasit, Babil, Karbala, Najaf, Al‐Diwaniyah, Muthanna, Maysan, DhiQar and Basra. The total number of infected cows and calves reported was 7396 and 227, respectively. The apparent morbidity and mortality rates were 9.11% and 0.51%, respectively, while the apparent case‐fatality rate was 5.56%. Skin nodules, anorexia, reduce in milk production and decrease in bodyweight were the common clinical signs. Moreover, myiasis and mastitis were seen as complications in some infected animals. Attempts were made to stop the distribution of the disease including quarantine and treatment, control over animal movement and arthropod control. Ring vaccination was used in a 10 km radius zone around the outbreak with live sheep pox vaccine. The highly contagious transboundary nature of the LSD, its endemic distribution in the Iraqi neighbouring countries, and the current armed conflict in the area were the possible factors for the disease being introduced into the country. LSD had spread through the Middle East and Gulf peninsula and could be a cause of danger to the rest of Asia and Europe. International precaution, cooperation and exchange of information could guarantee the prevention and further spread of the disease to the rest of Asia and Europe. 相似文献
89.
90.
Leigh syndrome (LS) is an inherited mitochondrial encephalopathy associated with gene mutations of oxidative phosphorylation pathway that result in early disability and death in affected young children. Currently, LS is incurable and unresponsive to many treatments, although some case reports indicate that supplements can improve the condition. Many novel therapies are being continuously tested in pre‐clinical studies. In this review, we summarize the genetic basis of LS, current treatment, pre‐clinical studies in animal models and the management of other mitochondrial diseases. Future therapeutical strategies and challenges are also discussed. 相似文献